Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma.

J Cachexia Sarcopenia Muscle · 2025 · PMC11886412 · PMID 40052383

Europe PMC DOI

hedged sentence

0.2190

closest p · 4.4× alpha

0.2190

boldest claim

The sentences

showed a trendp = 0.219not close (p > 0.1)

Patients with myosteatosis in the PD‐1 inhibitor + CTLA‐4 inhibitor group had no difference in OS ( p = 0.723) from those without and showed a trend towards improved PFS ( p = 0.219).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.